Patrick Tricoli

Patrick Tricoli serves as a Member of the Board of Directors for ReST THERAPEUTICS and NAYA Biosciences, and as a Foreign Trade Advisor to the French government with CCEF - Comite de Boston - Nouvelle Angleterre. From September 2014 to September 2024, Patrick held the roles of Chief Executive Officer of Nanobiotix USA and Head of Global Business Development, as well as President of Nanobiotix Corp. Previously, Patrick was the President of the Board at Curadigm and contributed to Global R&D Strategy at Sanofi. Patrick's earlier career includes significant positions at sanofi-aventis and SYNTHELABO, focusing on technology valorization and project leadership in pharmacology. Educational achievements include an Executive MBA from ESCP Business School and advanced degrees in Pharmaceutical Sciences from Université Claude Bernard Lyon 1.